67983-55-5Relevant articles and documents
Progesterone antagonists for the production of pharmaceutical agents for the treatment of dysfunctional uterine bleeding
-
, (2008/06/13)
Competitive progesterone antagonists (antigestagens) are suitable for the production of pharmaceutical agents for the treatment of forms of dysfunctional uterine bleeding (metrorrhagias, menorrhagias, hypermenorrhea).
REGIO AND STEREOSPECIFIC SYNTHESIS OF 11β-SUBSTITUTED 19-NORSTEROIDS. Influence of 11β-substitution on progesterone receptor affinity.
Belanger, A.,Philibert, D.,Teutsch, G.
, p. 361 - 382 (2007/10/02)
The convenient synthesis of a series of 11β-substituted 17-ethynyl-17β-hydroxy-4,9-estradien-3-ones and their corresponding estradiols is reported.Relative affinities for the progestin and estrogen receptors showed very specific interactions between the p